Seres Therapeutics
MCRB
MCRB
134 hedge funds and large institutions have $256M invested in Seres Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
2% less funds holding
Funds holding: 137 → 134 (-3)
53% less capital invested
Capital invested by funds: $538M → $256M (-$282M)
Holders
134
Holding in Top 10
2
Calls
$6.72M
Puts
$1.03M
Top Buyers
| 1 | +$4.11M | |
| 2 | +$2.67M | |
| 3 | +$2.31M | |
| 4 |
BlackRock
New York
|
+$1.05M |
| 5 |
Citigroup
New York
|
+$547K |
Top Sellers
| 1 | -$7.76M | |
| 2 | -$6.67M | |
| 3 | -$5.74M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.49M |
| 5 |
Millennium Management
New York
|
-$2.31M |